相似文献
1
ACS chemical neuroscience molecule spotlight on BMS-708163.
ACS Chem Neurosci. 2012 Mar 21;3(3):149-50. doi: 10.1021/cn3000179.
2
ACS chemical neuroscience molecule spotlight on Begacestat (GSI-953).
ACS Chem Neurosci. 2012 Jan 18;3(1):3-4. doi: 10.1021/cn200124u.
3
ACS chemical neuroscience molecule spotlight on ELND006: another γ-secretase inhibitor fails in the clinic.
ACS Chem Neurosci. 2011 Jun 15;2(6):279-80. doi: 10.1021/cn2000469.
4
BMS-708,163 targets presenilin and lacks notch-sparing activity.
Biochemistry. 2012 Sep 18;51(37):7209-11. doi: 10.1021/bi301137h. Epub 2012 Sep 4.
5
Mapping the Binding Site of BMS-708163 on γ-Secretase with Cleavable Photoprobes.
Cell Chem Biol. 2017 Jan 19;24(1):3-8. doi: 10.1016/j.chembiol.2016.12.006. Epub 2017 Jan 5.
6
Discovery of a novel sulfonamide-pyrazolopiperidine series as potent and efficacious gamma-secretase inhibitors.
Bioorg Med Chem Lett. 2010 Apr 1;20(7):2195-9. doi: 10.1016/j.bmcl.2010.02.039. Epub 2010 Feb 13.
7
Discovery of begacestat, a Notch-1-sparing gamma-secretase inhibitor for the treatment of Alzheimer's disease.
J Med Chem. 2008 Dec 11;51(23):7348-51. doi: 10.1021/jm801252w.
8
Begacestat (GSI-953): a novel, selective thiophene sulfonamide inhibitor of amyloid precursor protein gamma-secretase for the treatment of Alzheimer's disease.
J Pharmacol Exp Ther. 2009 Nov;331(2):598-608. doi: 10.1124/jpet.109.152975. Epub 2009 Aug 11.
9
N-Bridged bicyclic sulfonamides as inhibitors of gamma-secretase.
Bioorg Med Chem Lett. 2009 Dec 15;19(24):6952-6. doi: 10.1016/j.bmcl.2009.10.060. Epub 2009 Oct 30.
10
Synthesis and structure-activity relationship of a novel series of heterocyclic sulfonamide gamma-secretase inhibitors.
Bioorg Med Chem. 2009 Jul 1;17(13):4708-17. doi: 10.1016/j.bmc.2009.04.052. Epub 2009 May 3.
引用本文的文献
1
Synthesize heterogeneous biological knowledge via representation learning for Alzheimer's disease drug repurposing.
iScience. 2022 Nov 26;26(1):105678. doi: 10.1016/j.isci.2022.105678. eCollection 2023 Jan 20.
2
An Overview of Several Inhibitors for Alzheimer's Disease: Characterization and Failure.
Int J Mol Sci. 2021 Oct 6;22(19):10798. doi: 10.3390/ijms221910798.
3
Practical Method for Preparation of ()-2-Amino-5,5,5-trifluoropentanoic Acid via Dynamic Kinetic Resolution.
ACS Omega. 2019 Jul 9;4(7):11844-11851. doi: 10.1021/acsomega.9b01537. eCollection 2019 Jul 31.
本文引用的文献
1
Discovery and Evaluation of BMS-708163, a Potent, Selective and Orally Bioavailable γ-Secretase Inhibitor.
ACS Med Chem Lett. 2010 Mar 22;1(3):120-4. doi: 10.1021/ml1000239. eCollection 2010 Jun 10.
2
ACS chemical neuroscience molecule spotlight on Begacestat (GSI-953).
ACS Chem Neurosci. 2012 Jan 18;3(1):3-4. doi: 10.1021/cn200124u.
3
ACS chemical neuroscience molecule spotlight on ELND006: another γ-secretase inhibitor fails in the clinic.
ACS Chem Neurosci. 2011 Jun 15;2(6):279-80. doi: 10.1021/cn2000469.
4
ACS chemical neuroscience molecule spotlight on semagacestat (LY450139).
ACS Chem Neurosci. 2010 Aug 18;1(8):533-4. doi: 10.1021/cn1000606.
5
Alzheimer's disease: from pathology to therapeutic approaches.
Angew Chem Int Ed Engl. 2009;48(17):3030-59. doi: 10.1002/anie.200802808.
6
The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics.
Science. 2002 Jul 19;297(5580):353-6. doi: 10.1126/science.1072994.
7
Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE.
Science. 1999 Oct 22;286(5440):735-41. doi: 10.1126/science.286.5440.735.
8
The molecular pathology of Alzheimer's disease.
Neuron. 1991 Apr;6(4):487-98. doi: 10.1016/0896-6273(91)90052-2.
9
Alzheimer's disease: the amyloid cascade hypothesis.
Science. 1992 Apr 10;256(5054):184-5. doi: 10.1126/science.1566067.
Zotero 插件